应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TBPH Theravance Biopharma Inc.
已收盘 05-08 16:00:00 EDT
9.90
-0.09
-0.90%
盘后
9.90
+0.00
0.00%
16:05 EDT
最高
10.04
最低
9.64
成交量
34.30万
今开
9.96
昨收
9.99
日振幅
4.00%
总市值
4.95亿
流通市值
2.25亿
总股本
5,000万
成交额
337.99万
换手率
1.51%
流通股本
2,276万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Theravance Biopharma(TBPH.US):2025年Q1财报实现营收1538.8万美元,前值为1450.3万美元,预期值为2807万美元;每股收益为-0.27美元,前值为-0.09美元,预期值为-0.09美元。
金融界 · 05-08 20:12
Theravance Biopharma(TBPH.US):2025年Q1财报实现营收1538.8万美元,前值为1450.3万美元,预期值为2807万美元;每股收益为-0.27美元,前值为-0.09美元,预期值为-0.09美元。
Theravance Biopharma, Inc.盘中异动 快速上涨5.34%报9.08美元
市场透视 · 04-21
Theravance Biopharma, Inc.盘中异动 快速上涨5.34%报9.08美元
Theravance Biopharma, Inc.盘中异动 大幅拉升5.16%报9.57美元
市场透视 · 03-05
Theravance Biopharma, Inc.盘中异动 大幅拉升5.16%报9.57美元
Theravance Biopharma, Inc.2024财年实现净利润-56.42百万美元,同比减少2.23%
市场透视 · 03-02
Theravance Biopharma, Inc.2024财年实现净利润-56.42百万美元,同比减少2.23%
Theravance Biopharma, Inc.盘中异动 股价大涨8.81%
市场透视 · 02-27
Theravance Biopharma, Inc.盘中异动 股价大涨8.81%
Theravance Biopharma 第四季度调整后EPS $(0.05) 优于预期 $(0.21),销售额 $1875万 超预期 $1709万
财报速递 · 02-26
Theravance Biopharma 第四季度调整后EPS $(0.05) 优于预期 $(0.21),销售额 $1875万 超预期 $1709万
Theravance Biopharma, Inc.盘中异动 临近收盘急速跳水5.05%
市场透视 · 02-24
Theravance Biopharma, Inc.盘中异动 临近收盘急速跳水5.05%
Theravance Biopharma, Inc.盘中异动 急速下跌5.16%
市场透视 · 01-27
Theravance Biopharma, Inc.盘中异动 急速下跌5.16%
Theravance Biopharma, Inc.盘中异动 早盘股价大涨6.51%报10.30美元
市场透视 · 01-24
Theravance Biopharma, Inc.盘中异动 早盘股价大涨6.51%报10.30美元
Theravance Biopharma, Inc.盘中异动 急速拉升5.01%报9.01美元
市场透视 · 01-21
Theravance Biopharma, Inc.盘中异动 急速拉升5.01%报9.01美元
Theravance Biopharma, Inc.盘中异动 股价大涨5.06%报9.97美元
市场透视 · 2024-11-19
Theravance Biopharma, Inc.盘中异动 股价大涨5.06%报9.97美元
Theravance Biopharma, Inc.盘中异动 早盘快速上涨6.29%报9.47美元
市场透视 · 2024-11-13
Theravance Biopharma, Inc.盘中异动 早盘快速上涨6.29%报9.47美元
Theravance Biopharma, Inc.盘中异动 股价大涨5.14%报8.70美元
市场透视 · 2024-11-06
Theravance Biopharma, Inc.盘中异动 股价大涨5.14%报8.70美元
Theravance Biopharma, Inc.盘中异动 大幅拉升6.01%
市场透视 · 2024-10-15
Theravance Biopharma, Inc.盘中异动 大幅拉升6.01%
加载更多
公司概况
公司名称:
Theravance Biopharma Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Theravance Biopharma, Inc.,于2013年7月注册为开曼群岛豁免股份有限公司。该公司是一家生物制药公司,主要专注于药物的发现、开发和商业化。该公司的核心宗旨是创造能够改变人们生活的药物。该公司利用数十年的专业知识,开发了FDA批准的YUPELRI(revefenacin)吸入溶液,用于慢性阻塞性肺病患者的维持治疗。
发行价格:
--
{"stockData":{"symbol":"TBPH","market":"US","secType":"STK","nameCN":"Theravance Biopharma Inc.","latestPrice":9.9,"timestamp":1746734400000,"preClose":9.99,"halted":0,"volume":342990,"hourTrading":{"tag":"盘后","latestPrice":9.9,"preClose":9.9,"latestTime":"16:05 EDT","volume":1564,"amount":15465.6,"timestamp":1746734712108},"delay":0,"floatShares":22758721,"shares":50001332,"eps":-1.154994,"marketStatus":"已收盘","change":-0.09,"latestTime":"05-08 16:00:00 EDT","open":9.96,"high":10.04,"low":9.64,"amount":3379943.84949,"amplitude":0.04004,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.154994,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746777600000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1400212800000,"exchange":"NASDAQ","adjPreClose":9.99,"preHourTrading":{"tag":"盘前","latestPrice":9.83,"preClose":9.99,"latestTime":"09:27 EDT","volume":510,"amount":5009.58057,"timestamp":1746710870080},"postHourTrading":{"tag":"盘后","latestPrice":9.9,"preClose":9.9,"latestTime":"16:05 EDT","volume":1564,"amount":15465.6,"timestamp":1746734712108},"volumeRatio":1.165618,"impliedVol":0.4269,"impliedVolPercentile":0.34},"requestUrl":"/m/hq/s/TBPH","defaultTab":"news","newsList":[{"id":"2534696741","title":"Theravance Biopharma(TBPH.US):2025年Q1财报实现营收1538.8万美元,前值为1450.3万美元,预期值为2807万美元;每股收益为-0.27美元,前值为-0.09美元,预期值为-0.09美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534696741","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534696741?lang=zh_cn&edition=full","pubTime":"2025-05-09 04:12","pubTimestamp":1746735140,"startTime":"0","endTime":"0","summary":"Theravance Biopharma(TBPH.US):2025年Q1财报实现营收1538.8万美元,前值为1450.3万美元,预期值为2807万美元;每股收益为-0.27美元,前值为-0.09美元,预期值为-0.09美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/09041250242977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["TBPH"],"gpt_icon":0},{"id":"2529858330","title":"Theravance Biopharma, Inc.盘中异动 快速上涨5.34%报9.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529858330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529858330?lang=zh_cn&edition=full","pubTime":"2025-04-22 03:32","pubTimestamp":1745263962,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日03时32分,Theravance Biopharma, Inc.股票出现异动,股价快速拉升5.34%。Theravance Biopharma, Inc.股票所在的生物技术行业中,整体跌幅为0.82%。其相关个股中,Revolution Medicines Inc C/Wts 17/12/2026 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Cardio Diagnostics Holdings Inc C/Wts To Pur Com涨幅较大,Transcode Therapeutics, Inc.、Aptevo Therapeutics Inc.、Dogwood Therapeutics, Inc.较为活跃,换手率分别为1870.55%、1730.11%、1083.40%,振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Geovax Labs Inc C/Wts 29/09/2025、Aptevo Therapeutics Inc.,振幅分别为119.47%、111.18%、86.59%。Theravance Biopharma, Inc.公司简介:Theravance Biopharma Inc 是一家多元化的生物制药公司,专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422033243973fb141&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422033243973fb141&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2517427629","title":"Theravance Biopharma, Inc.盘中异动 大幅拉升5.16%报9.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517427629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517427629?lang=zh_cn&edition=full","pubTime":"2025-03-06 01:20","pubTimestamp":1741195237,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日01时20分,Theravance Biopharma, Inc.股票出现波动,股价急速拉升5.16%。Theravance Biopharma, Inc.股票所在的生物技术行业中,整体涨幅为1.15%。其相关个股中,Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nutriband Inc C/Wts 涨幅较大,Silexion Therapeutics Corp、Tc Biopharm Plc、Bioxcel Therapeutics, Inc.较为活跃,换手率分别为933.95%、303.15%、289.83%,振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc.,振幅分别为82.59%、54.27%、47.22%。Theravance Biopharma, Inc.公司简介:Theravance Biopharma Inc 是一家多元化的生物制药公司,专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306012037989d6bab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306012037989d6bab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2516754802","title":"Theravance Biopharma, Inc.2024财年实现净利润-56.42百万美元,同比减少2.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516754802","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516754802?lang=zh_cn&edition=full","pubTime":"2025-03-03 00:01","pubTimestamp":1740931279,"startTime":"0","endTime":"0","summary":"3月3日,Theravance Biopharma, Inc.公布财报,公告显示公司2024财年净利润为-56.42百万美元,同比减少2.23%;其中营业收入为64.38百万美元,同比增加12.12%,每股基本收益为-1.16美元。机构评级:截至2025年3月3日,当前有4家机构对Theravance Biopharma, Inc.目标价做出预测,其中目标均价为14.50美元,其中最低目标价为10.00美元,最高目标价为21.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000156a25bbc84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000156a25bbc84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TBPH"],"gpt_icon":0},{"id":"2514385130","title":"Theravance Biopharma, Inc.盘中异动 股价大涨8.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385130","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514385130?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:31","pubTimestamp":1740666678,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时31分,Theravance Biopharma, Inc.股票出现异动,股价急速上涨8.81%。Theravance Biopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.06%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Quoin Pharmaceuticals Ltd、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大,Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃,换手率分别为394.03%、90.29%、48.43%,振幅较大的相关个股有天演药业、Syros Pharmaceuticals, Inc.、内克塔治疗,振幅分别为10.10%、10.09%、7.64%。Theravance Biopharma, Inc.公司简介:Theravance Biopharma Inc 是一家多元化的生物制药公司,专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223118abdf6e6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223118abdf6e6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TBPH"],"gpt_icon":0},{"id":"1107161536","title":"Theravance Biopharma 第四季度调整后EPS $(0.05) 优于预期 $(0.21),销售额 $1875万 超预期 $1709万","url":"https://stock-news.laohu8.com/highlight/detail?id=1107161536","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107161536?lang=zh_cn&edition=full","pubTime":"2025-02-27 05:33","pubTimestamp":1740605625,"startTime":"0","endTime":"0","summary":"Theravance Biopharma 公布季度每股亏损 $,比分析师一致预期的 $ 高出76.19%。这比去年同期每股亏损 $ 增加了70.59%。以上内容来自Benzinga Earnings专栏,原文如下:Theravance Biopharma reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 76.19 percent. This is a 70.59 percent increase over losses of $ per share from the same period last year. The company reported quarterly sales of $18.75 million which beat the analyst consensus estimate of $17.09 million by 9.73 percent. This is a 6.77 percent increase over s","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Theravance Biopharma 第四季度调整后EPS $(0.05) 优于预期 $(0.21),销售额 $1875万 超预期 $1709万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH"],"gpt_icon":0},{"id":"2514705216","title":"Theravance Biopharma, Inc.盘中异动 临近收盘急速跳水5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514705216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514705216?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:55","pubTimestamp":1740430544,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时55分,Theravance Biopharma, Inc.股票出现波动,股价大幅下挫5.05%。Theravance Biopharma, Inc.股票所在的生物技术行业中,整体跌幅为0.41%。其相关个股中,Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大,Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为332.71%、145.46%、41.78%,振幅较大的相关个股有Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 ,振幅分别为176.22%、164.23%、81.92%。Theravance Biopharma, Inc.公司简介:Theravance Biopharma Inc 是一家多元化的生物制药公司,专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022504554498913f99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022504554498913f99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TBPH"],"gpt_icon":0},{"id":"2506309225","title":"Theravance Biopharma, Inc.盘中异动 急速下跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506309225","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506309225?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:14","pubTimestamp":1737990865,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时14分,Theravance Biopharma, Inc.股票出现波动,股价快速下跌5.16%。Theravance Biopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.98%。其相关个股中,Akero Therapeutics, Inc.、Onconetix, Inc.、89Bio, Inc.涨幅较大,Onconetix, Inc.、Evaxion Biotech As、Dogwood Therapeutics, Inc.较为活跃,换手率分别为1714.17%、188.57%、164.70%,振幅较大的相关个股有阿诺医药、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028,振幅分别为98.54%、85.35%、65.16%。Theravance Biopharma, Inc.公司简介:Theravance Biopharma Inc 是一家多元化的生物制药公司,专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012723142696124086&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012723142696124086&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TBPH"],"gpt_icon":0},{"id":"2506908860","title":"Theravance Biopharma, Inc.盘中异动 早盘股价大涨6.51%报10.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506908860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506908860?lang=zh_cn&edition=full","pubTime":"2025-01-25 00:19","pubTimestamp":1737735568,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日00时19分,Theravance Biopharma, Inc.股票出现波动,股价快速拉升6.51%。截至发稿,该股报10.30美元/股,成交量8.9241万股,换手率0.18%,振幅5.44%。Theravance Biopharma, Inc.股票所在的生物技术行业中,整体跌幅为0.05%。Theravance Biopharma, Inc.公司简介:Theravance Biopharma Inc 是一家多元化的生物制药公司,专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125001929a22e7240&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125001929a22e7240&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2505205340","title":"Theravance Biopharma, Inc.盘中异动 急速拉升5.01%报9.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505205340","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505205340?lang=zh_cn&edition=full","pubTime":"2025-01-22 00:16","pubTimestamp":1737476195,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日00时16分,Theravance Biopharma, Inc.股票出现异动,股价快速拉升5.01%。Theravance Biopharma, Inc.股票所在的生物技术行业中,整体涨幅为1.63%。其相关个股中,Channel Therapeutics Corporation、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Dogwood Therapeutics, Inc.涨幅较大,Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃,换手率分别为755.88%、472.32%、182.27%,振幅较大的相关个股有Channel Therapeutics Corporation、Klotho Neurosciences Inc C/Wts 21/06/2029 、Dogwood Therapeutics, Inc.,振幅分别为96.32%、41.33%、38.48%。Theravance Biopharma, Inc.公司简介:Theravance Biopharma Inc 是一家多元化的生物制药公司,专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122001635986e4695&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122001635986e4695&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2484979041","title":"Theravance Biopharma, Inc.盘中异动 股价大涨5.06%报9.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484979041","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484979041?lang=zh_cn&edition=full","pubTime":"2024-11-20 02:41","pubTimestamp":1732041679,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日02时41分,Theravance Biopharma, Inc.股票出现波动,股价快速上涨5.06%。Theravance Biopharma, Inc.股票所在的生物技术行业中,整体跌幅为1.33%。其相关个股中,Syros Pharmaceuticals, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Syros Pharmaceuticals, Inc.、Tff Pharmaceuticals, Inc.、Exicure, Inc.较为活跃,换手率分别为1019.69%、836.68%、141.70%,振幅较大的相关个股有Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ,振幅分别为91.10%、81.67%、62.82%。Theravance Biopharma, Inc.公司简介:Theravance Biopharma Inc 是一家多元化的生物制药公司,专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112002411998e4391e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112002411998e4391e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2483300884","title":"Theravance Biopharma, Inc.盘中异动 早盘快速上涨6.29%报9.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483300884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483300884?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:31","pubTimestamp":1731508275,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时31分,Theravance Biopharma, Inc.股票出现异动,股价快速拉升6.29%。Theravance Biopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.05%。其相关个股中,Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Kairos Pharma, Ltd.涨幅较大,Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃,换手率分别为323.85%、168.31%、84.06%,振幅较大的相关个股有Entero Therapeutics Inc.、Turnstone Biologics Corp.、Cyclacel Pharmaceuticals, Inc.,振幅分别为8.29%、7.65%、7.63%。Theravance Biopharma, Inc.公司简介:Theravance Biopharma Inc 是一家多元化的生物制药公司,专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322311595be230e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322311595be230e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TBPH"],"gpt_icon":0},{"id":"2481939798","title":"Theravance Biopharma, Inc.盘中异动 股价大涨5.14%报8.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481939798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481939798?lang=zh_cn&edition=full","pubTime":"2024-11-07 02:02","pubTimestamp":1730916162,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日02时02分,Theravance Biopharma, Inc.股票出现波动,股价急速上涨5.14%。Theravance Biopharma, Inc.股票所在的生物技术行业中,整体跌幅为0.35%。其相关个股中,60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Sonnet Biotherapeutics Holdings, Inc.涨幅较大,Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃,换手率分别为3021.40%、425.92%、133.19%,振幅较大的相关个股有Cardio Diagnostics Holdings Inc.、Sonnet Biotherapeutics Holdings, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ,振幅分别为82.72%、77.67%、57.62%。Theravance Biopharma, Inc.公司简介:Theravance Biopharma Inc 是一家多元化的生物制药公司,专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107020242a21d9460&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107020242a21d9460&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2475667712","title":"Theravance Biopharma, Inc.盘中异动 大幅拉升6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475667712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475667712?lang=zh_cn&edition=full","pubTime":"2024-10-16 03:48","pubTimestamp":1729021733,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日03时48分,Theravance Biopharma, Inc.股票出现波动,股价快速上涨6.01%。Theravance Biopharma, Inc.股票所在的生物技术行业中,整体跌幅为0.57%。其相关个股中,Bright Minds Biosciences Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大,Bright Minds Biosciences Inc.、Salarius Pharmaceuticals, Inc.、Aditxt, Inc.较为活跃,换手率分别为2154.74%、501.88%、413.94%,振幅较大的相关个股有Bright Minds Biosciences Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Apollomics Inc C/Wts 01/04/2028 ,振幅分别为1204.82%、173.40%、123.44%。Theravance Biopharma, Inc.公司简介:Theravance Biopharma Inc 是一家多元化的生物制药公司,专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101603485398e3c9dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101603485398e3c9dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TBPH","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.theravance.com","stockEarnings":[{"period":"1week","weight":0.0225},{"period":"1month","weight":0.1879},{"period":"3month","weight":0.0505},{"period":"6month","weight":0.1174},{"period":"1year","weight":0.0472},{"period":"ytd","weight":0.0616}],"compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":0.1126},{"period":"3month","weight":-0.0745},{"period":"6month","weight":-0.0619},{"period":"1year","weight":0.0851},{"period":"ytd","weight":-0.0425}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Theravance Biopharma, Inc.,于2013年7月注册为开曼群岛豁免股份有限公司。该公司是一家生物制药公司,主要专注于药物的发现、开发和商业化。该公司的核心宗旨是创造能够改变人们生活的药物。该公司利用数十年的专业知识,开发了FDA批准的YUPELRI(revefenacin)吸入溶液,用于慢性阻塞性肺病患者的维持治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.022727},{"month":2,"riseRate":0.272727,"avgChangeRate":0.009876},{"month":3,"riseRate":0.363636,"avgChangeRate":0.007997},{"month":4,"riseRate":0.545455,"avgChangeRate":0.039762},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.061753},{"month":6,"riseRate":0.2,"avgChangeRate":-0.046131},{"month":7,"riseRate":0.363636,"avgChangeRate":0.003912},{"month":8,"riseRate":0.636364,"avgChangeRate":-0.000873},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.037754},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.028238},{"month":11,"riseRate":0.727273,"avgChangeRate":0.088318},{"month":12,"riseRate":0.636364,"avgChangeRate":0.052504}],"exchange":"NASDAQ","name":"Theravance Biopharma Inc.","nameEN":"Theravance Biopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Theravance Biopharma Inc.(TBPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Theravance Biopharma Inc.(TBPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Theravance Biopharma Inc.,TBPH,Theravance Biopharma Inc.股票,Theravance Biopharma Inc.股票老虎,Theravance Biopharma Inc.股票老虎国际,Theravance Biopharma Inc.行情,Theravance Biopharma Inc.股票行情,Theravance Biopharma Inc.股价,Theravance Biopharma Inc.股市,Theravance Biopharma Inc.股票价格,Theravance Biopharma Inc.股票交易,Theravance Biopharma Inc.股票购买,Theravance Biopharma Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Theravance Biopharma Inc.(TBPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Theravance Biopharma Inc.(TBPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}